Watermark
  Back to Search Results

ZWI-ZW25-301

Active, not recruiting

A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

ZWI-ZW25-301

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT05152147

EudraCT or EUCT Number Info icon SVG graphic used for tooltips or additional information.

2023

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents